Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page
- Check5 days agoChange DetectedThe record history now contains a new revision label v3.7.0, replacing the previous v3.6.6 entry and updating the version history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new site revision tag 'Revision: v3.6.6' was added to the page, signaling a deployment of a newer version of the ClinicalTrials.gov interface and related updates to the record history view.SummaryDifference0.1%

- Check33 days agoChange DetectedThe study history now includes a new 'Study Status' entry and an updated version count (15) in the Study Record Versions section, indicating the latest status and the addition of a new version in the record.SummaryDifference0.4%

- Check48 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing v3.6.4, indicating a maintenance update to the ClinicalTrials.gov interface without changes to the study record.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record history now displays a new site revision, v3.6.4, replacing the previous v3.6.3, signaling a backend or UI update to the page.SummaryDifference0.1%

- Check84 days agoChange DetectedThe study history shows a new revision entry for version v3.6.3, updating the record from v3.6.2.SummaryDifference0.1%

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.